KUALA LUMPUR, Malaysia, Sept. 12, 2024 /PRNewswire/ — In celebration of the 50th anniversary of diplomatic relations between Malaysia and China, the inaugural 2024 Malaysia E-Commerce Product Selection Expo will be held from November 29 to December 1 at the Malaysia International Trade and Exhibition Centre (MITEC), Malaysia’s largest trade exhibition venue. Jointly organised by the Malaysia […]
Category Archives: Pr Newswire
NEDRE VATS, Norway, Sept. 13, 2024 /PRNewswire/ — Today, AutoStore™ introduces new Grid capabilities: the AutoStore™ Multi-Temperature Solution™, an expanded 18-Level Grid, a Motorized Service Vehicle and enhancements to the cube control software. Building on AutoStore’s foundation of unmatched density, efficiency, and scalability, these innovations will help businesses maintain a competitive edge with their automated fulfillment solutions. […]
WEST PALM BEACH, Fla., Sept. 13, 2024 /PRNewswire/ — Elliott Investment Management L.P. (“Elliott”), today issued the following statement: On September 12, 2024, the Republic of Korea (“ROK”) filed court papers to appeal the High Court of England and Wales’s (the “English Court”) dismissal of its application to set aside the US $100 million Arbitral […]
Pr Newswire
VYNE Therapeutics Announces Positive Phase 1a SAD Data for VYN202, a Novel BD2-Selective BET Inhibitor
12
Sep
Sep
VYN202 was generally well tolerated with no drug-related adverse events Pharmacokinetic results demonstrated dose-dependent exposure of VYN202 in blood Pharmacodynamic activity observed on target engagement and inflammatory biomarkers Dosing has begun in the MAD portion of the trial with results expected in Q4 2024 BRIDGEWATER, N.J., Sept. 12, 2024 (GLOBE NEWSWIRE) — VYNE Therapeutics Inc. (Nasdaq: […]
Pr Newswire
Monopar Announces Positive Early Human Clinical Data Validating the Tumor Targeting Ability of MNPR-101-Zr
12
Sep
Sep
WILMETTE, Ill., Sept. 12, 2024 (GLOBE NEWSWIRE) — Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage radiopharma company focused on developing innovative treatments for cancer patients, today announced positive early data from its ongoing open-label MNPR-101-Zr Phase 1 imaging and dosimetry clinical trial confirming MNPR-101-Zr’s tumor targeting ability in humans. MNPR-101 is Monopar’s proprietary first-in-class humanized […]
12
Sep
Sep
CHARLESTOWN, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) — Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company” or “Solid”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced that Bo Cumbo, President and CEO, and Gabriel Brooks, M.D., Chief Medical Officer, will participate in a fireside chat at the 2024 Cantor […]
Pr Newswire
Sharps Technology Announces Continued Listing on Nasdaq Pending Results of an Upcoming Special Shareholders’ Meeting
12
Sep
Sep
NEW YORK, Sept. 12, 2024 (GLOBE NEWSWIRE) — Sharps Technology, Inc., (NASDAQ: STSS and STSSW) (“Sharps Technology” or the “Company”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, announced today that the Company has secured approval from The Nasdaq Stock Market (“Nasdaq” or the “Exchange”) to maintain its listing, subject […]
Pr Newswire
Sernova Announces New Positive Data from Phase I/II Trial Regarding Islet Survival and Function
12
Sep
Sep
Abundant, richly vascularized and functioning islets observed throughout all chambers of Sernova’s Cell Pouch more than 5 years after islet transplantation Histological data confirmation of healthy beta, alpha and delta cells secreting insulin, glucagon, and somatostatin in all Cell Pouch Chambers Sernova’s Cell Pouch safely contains its therapeutic cells and provides full retrievability using conventional […]
BEIJING, Sept. 12, 2024 /PRNewswire/ — CPA Australia is honoured to participate in the Australian Country Pavilion at the 2024 China International Fair for Trade in Services (CIFTIS) as a platinum partner for the first time. This participation highlights CPA Australia’s ongoing commitment to strengthening bilateral trade and commerce collaborations between Australia and China as […]
PISCATAWAY, N.J., Sept. 12, 2024 /PRNewswire/ — GenScript Biotech Corporation (“GenScript”), a global leader in life sciences products and services, announced the appointment of Dr. Ross Allen Grossman as a Non-Executive Director and Dr. Alphonse Galdes as an Independent Non-Executive Director. These appointments not only further diversify the Group’s Board but also highlight GenScript’s commitment […]